ARIAD Pharmaceuticals
ARIAD is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$5.2b Valuation: $5.2b | Acquisition | ||
| Total Funding | 000k | ||
Merlin Biomed(exited)
Medicxi(exited)
Credit Suisse(exited)
Avalon Ventures(exited)
Wellington Access Ventures(exited)
BB Biotech(exited)
Forward Ventures(exited)
| EUR | 2015 |
|---|---|
| Revenues | 0000 |
| EBITDA | 0000 |
| Profit | 0000 |
| EV | 0000 |
| EV / revenue | 00.0x |
| EV / EBITDA | 00.0x |
| R&D budget | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by ARIAD Pharmaceuticals
Edit
ACQUISITION by Concentra Biosciences Dec 2023